Development and validation of the Food Allergy Severity Score

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3000002 38 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Development and validation of the Food Allergy Severity Score
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Background: The heterogeneity and lack of validation of existing severity scores for food allergic reactions limit standardization of case management and research advances. We aimed to develop and validate a severity score for food allergic reactions. Methods: Following a multidisciplinary experts consensus, it was decided to develop a food allergy severity score (FASS) with ordinal (oFASS) and numerical (nFASS) formats. oFASS with 3 and 5 grades were generated through expert consensus, and nFASS by mathematical modeling. Evaluation was performed in the EuroPrevall outpatient clinic cohort (8232 food reactions) by logistic regression with request of emergency care and medications used as outcomes. Discrimination, classification, and calibration were calculated. Bootstrapping internal validation was followed by external validation (logistic regression) in 5 cohorts (3622 food reactions). Correlation of nFASS with the severity classification done by expert allergy clinicians by Best-Worst Scaling of 32 food reactions was calculated. Results: oFASS and nFASS map consistently, with nFASS having greater granularity. With the outcomes emergency care, adrenaline and critical medical treatment, oFASS and nFASS had a good discrimination (receiver operating characteristic area under the curve [ROC-AUC]>0.80), classification (sensitivity 0.87–0.92, specificity 0.73–0.78), and calibration. Bootstrapping over ROC-AUC showed negligible biases (1.0 × 10−6–1.23 × 10−3). In external validation, nFASS performed best with higher ROC-AUC. nFASS was strongly correlated (R 0.89) to best-worst scoring of 334 expert clinicians. Conclusion: FASS is a validated and reliable method to measure severity of food allergic reactions. The ordinal and numerical versions that map onto each other are suitable for use by different stakeholders in different settings. © 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Έτος δημοσίευσης:
2021
Συγγραφείς:
Fernández-Rivas, M.
Gómez García, I.
Gonzalo-Fernández, A.
Fuentes Ferrer, M.
Dölle-Bierke, S.
Marco-Martín, G.
Ballmer-Weber, B.K.
Asero, R.
Belohlavkova, S.
Beyer, K.
de Blay, F.
Clausen, M.
Datema, M.R.
Dubakiene, R.
Grimshaw, K.E.C.
Hoffmann-Sommergruber, K.
Hourihane, J.O.B.
Jedrzejczak-Czechowicz, M.
Knulst, A.C.
Kralimarkova, T.
Le, T.-M.
Papadopoulos, N.G.
Popov, T.A.
Poulsen, L.K.
Purohit, A.
Seneviratne, S.L.
Simpson, A.
Sinaniotis, A.
Turkalji, M.
Vázquez-Cortés, S.
Vera-Berrios, R.N.
Muraro, A.
Worm, M.
Roberts, G.
van Ree, R.
Fernández-Pérez, C.
Turner, P.J.
Mills, E.N.C.
Περιοδικό:
Allergy: European Journal of Allergy and Clinical Immunology
Εκδότης:
John Wiley and Sons Inc
Επίσημο URL (Εκδότης):
DOI:
10.1111/all.15165
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.